The Eye Disease TCR Flagship Programme has filed two patents to date. While only less than two years into their funding, the TCR Flagship Programmes have demonstrated great promise from combining the clinical strengths and …
Continued here:
Singapore A*STAR Invests $36 Million In Medical Technology …
